← SynDRA
REMIMAZOLAM
SynDRA canonical compound SYN0039672 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Approval status | Approved · Rx |
| Primary target(s) | GABBR1 |
| Mechanism of action | benzodiazepine receptor agonist |
All known targets
- GABRG3
- GABRA2
- GABRA3
- GABRA5
- GABRA1
- GABRG1
- GABRG2
- GABBR1
- GABRP
- Gabrb2
- Gabra5
- Gabra3
Mechanisms of action (all sources)
- GABRA1 POSITIVE ALLOSTERIC MODULATOR
- GABRB2 POSITIVE ALLOSTERIC MODULATOR
- GABRG2 POSITIVE ALLOSTERIC MODULATOR
- GABRB3 POSITIVE ALLOSTERIC MODULATOR
- GABRA4 POSITIVE ALLOSTERIC MODULATOR
- GABRG3 POSITIVE ALLOSTERIC MODULATOR
- GABRQ POSITIVE ALLOSTERIC MODULATOR
- GABRA3 POSITIVE ALLOSTERIC MODULATOR
- GABRP POSITIVE ALLOSTERIC MODULATOR
- GABRD POSITIVE ALLOSTERIC MODULATOR
- GABRG1 POSITIVE ALLOSTERIC MODULATOR
- GABRB1 POSITIVE ALLOSTERIC MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
ATC classes
- N05C · HYPNOTICS AND SEDATIVES
Cross-references
Synonyms
- BYFAVO
- Byfavo
- remimazolam besylate
- byfavo
- CNS 7056
- CNS 7056B
- ONO-2745BS
- ONO-2745
- anerem
- aptimyda
- CNS-7056
- CNS-7054
- CNS-7056B
- CNS-7056X
- GW-351564X
- GW-418259X
- GW-457837A
- GW-502056X
- Short-acting sedatives, Therasci
- GABA A agonist (anesthesia, sedation) CeNeS/Ono
- Sedatives (short acting), CeNeS/Ono
- Sedatives (short acting), PAION/Ono
- Sedatives (short-acting), TheraSci
- Short-acting sedatives, Therasci/GSK
- Sedatives (short-acting), TheraSci/GSK
- ONO 2745
- 7V4A8U16MB
- ONO2745
- CNS7056
- remimazolamum
- RefChem:57866
- N05CD14
- Byfavo (TN)
- Remimazolam [INN]
- UNII-7V4A8U16MB
- REMIMAZOLAM [MI]
- Remimazolam (USAN/INN)
- Remimazolam [USAN:INN]
Reported adverse events
- Bradycardia
- Headache
- Hypotension
- Hypoxia
- Nausea
- Respiratory rate decreased
- Diastolic hypotension
- Blood pressure diastolic increased
- Blood pressure increased
- Blood pressure systolic increased
- Diastolic hypertension
- Hypertension
Look up REMIMAZOLAM in the interactive SynDRA portal →